Healthcare - Asia Pacific: Asia CDMO: industry update and thoughts on key market debates

Research evidence excerpt

Healthcare - Asia Pacific: Asia CDMO: industry update and thoughts on key market debates

Special Disclosures

In accordance with the SEBI (Foreign Portfolio Investors) Regulations, 2019 and

with guidelines issued by the Securities and Exchange Board of India (SEBI), foreign

investors (individuals as well as institutional) that wish to transact the common

stock of Indian companies must have applied to, and have been approved as per

SEBI (Foreign Portfolio Investors) Regulations, 2019. Each investor who proposes to

transact common stock of Indian companies will be required to obtain Foreign

Portfolio Investor (FPI) registration as per SEBI (Foreign Portfolio Investors)

Regulations, 2019. Certain other entities are also entitled to transact common stock

of Indian companies under the Indian laws relating to investment by foreigners.

BofA Securities reserves the right to refuse to provide a copy of research on

common stock of Indian companies to a person not resident in India. American

Depositary Receipts (ADR) representing such common stock are not subject to these

Indian law restrictions and may be transacted by investors in accordance with the

applicable laws of the relevant jurisdiction. Global Depository Receipts (GDR) and

the Global Depository Shares (GDS) of Indian companies, Indian limited liability

corporations, have not been registered under the U.S. Securities Act of 1933, as

amended, and may only be transacted by persons in the United States who are

Qualified Institutional Buyers (QIBs) within the meaning of Rule 144A under the

Securities Act. Accordingly, no copy of any research report on Indian companies'

GDRs or GDSs will be made available to persons who are not QIBs.

BofA Securities India Limited (BofAS India) is regulated by the Securities and